Cargando…

Techniques for estimating health care costs with censored data: an overview for the health services researcher

OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Wijeysundera, Harindra C, Wang, Xuesong, Tomlinson, George, Ko, Dennis T, Krahn, Murray D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377439/
https://www.ncbi.nlm.nih.gov/pubmed/22719214
http://dx.doi.org/10.2147/CEOR.S31552
_version_ 1782235957856043008
author Wijeysundera, Harindra C
Wang, Xuesong
Tomlinson, George
Ko, Dennis T
Krahn, Murray D
author_facet Wijeysundera, Harindra C
Wang, Xuesong
Tomlinson, George
Ko, Dennis T
Krahn, Murray D
author_sort Wijeysundera, Harindra C
collection PubMed
description OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advanced statistical background. METHODS: Data were sourced from longitudinal heart failure costs from Ontario, Canada, and administrative databases were used for estimating costs. The dataset consisted of 43,888 patients, with follow-up periods ranging from 1 to 1538 days (mean 576 days). The study was designed so that mean health care costs over 1080 days of follow-up were calculated using naïve estimators such as full-sample and uncensored case estimators. Reweighted estimators – specifically, the inverse probability weighted estimator – were calculated, as was phase-based costing. Costs were adjusted to 2008 Canadian dollars using the Bank of Canada consumer price index (http://www.bankofcanada.ca/en/cpi.html). RESULTS: Over the restricted follow-up of 1080 days, 32% of patients were censored. The full-sample estimator was found to underestimate mean cost ($30,420) compared with the reweighted estimators ($36,490). The phase-based costing estimate of $37,237 was similar to that of the simple reweighted estimator. CONCLUSION: The authors recommend against the use of full-sample or uncensored case estimators when censored data are present. In the presence of heavy censoring, phase-based costing is an attractive alternative approach.
format Online
Article
Text
id pubmed-3377439
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-33774392012-06-20 Techniques for estimating health care costs with censored data: an overview for the health services researcher Wijeysundera, Harindra C Wang, Xuesong Tomlinson, George Ko, Dennis T Krahn, Murray D Clinicoecon Outcomes Res Review OBJECTIVE: The aim of this study was to review statistical techniques for estimating the mean population cost using health care cost data that, because of the inability to achieve complete follow-up until death, are right censored. The target audience is health service researchers without an advanced statistical background. METHODS: Data were sourced from longitudinal heart failure costs from Ontario, Canada, and administrative databases were used for estimating costs. The dataset consisted of 43,888 patients, with follow-up periods ranging from 1 to 1538 days (mean 576 days). The study was designed so that mean health care costs over 1080 days of follow-up were calculated using naïve estimators such as full-sample and uncensored case estimators. Reweighted estimators – specifically, the inverse probability weighted estimator – were calculated, as was phase-based costing. Costs were adjusted to 2008 Canadian dollars using the Bank of Canada consumer price index (http://www.bankofcanada.ca/en/cpi.html). RESULTS: Over the restricted follow-up of 1080 days, 32% of patients were censored. The full-sample estimator was found to underestimate mean cost ($30,420) compared with the reweighted estimators ($36,490). The phase-based costing estimate of $37,237 was similar to that of the simple reweighted estimator. CONCLUSION: The authors recommend against the use of full-sample or uncensored case estimators when censored data are present. In the presence of heavy censoring, phase-based costing is an attractive alternative approach. Dove Medical Press 2012-06-01 /pmc/articles/PMC3377439/ /pubmed/22719214 http://dx.doi.org/10.2147/CEOR.S31552 Text en © 2012 Wijeysundera et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Review
Wijeysundera, Harindra C
Wang, Xuesong
Tomlinson, George
Ko, Dennis T
Krahn, Murray D
Techniques for estimating health care costs with censored data: an overview for the health services researcher
title Techniques for estimating health care costs with censored data: an overview for the health services researcher
title_full Techniques for estimating health care costs with censored data: an overview for the health services researcher
title_fullStr Techniques for estimating health care costs with censored data: an overview for the health services researcher
title_full_unstemmed Techniques for estimating health care costs with censored data: an overview for the health services researcher
title_short Techniques for estimating health care costs with censored data: an overview for the health services researcher
title_sort techniques for estimating health care costs with censored data: an overview for the health services researcher
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3377439/
https://www.ncbi.nlm.nih.gov/pubmed/22719214
http://dx.doi.org/10.2147/CEOR.S31552
work_keys_str_mv AT wijeysunderaharindrac techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher
AT wangxuesong techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher
AT tomlinsongeorge techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher
AT kodennist techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher
AT krahnmurrayd techniquesforestimatinghealthcarecostswithcensoreddataanoverviewforthehealthservicesresearcher